Business
EU regulators reviewing J&J’s COVID vaccine after blood clots – Aljazeera.com
Johnson & Johnson is working with EU regulators to assess data on the rare clots, the company said in a statement.
The European Unions drug regulator has started a review to assess blood clots in people who received Johnson & Johnsons Covid-19 vaccine.
Four serious cases of unusual clots accompanied by low blood platelets, one of which was fatal, have emerged after immunization with the J&J shot, the European Medicines Agency said Friday. The regulator is now scrutinizing potential safety issues for two Covid vaccines, after AstraZeneca Plcs shot was possibly linked to a rare blood-clotting disorder.
J&J is…
-
General15 hours agoAFL gives teams finishing 10th chance to win premiership through wildcard round in finals
-
General12 hours agoPrincess Anne remembers Porepunkah police officers in wreath-laying ceremony in Melbourne
-
Noosa News11 hours agoDingo hunts shark in shallow waters off K’gari, Queensland
-
Noosa News5 hours ago‘Just want to know he’s safe’: Family’s German Shepherd asleep in back of stolen ute